380 related articles for article (PubMed ID: 2947255)
21. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
22. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
23. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
de Paulis T; Kumar Y; Johansson L; Rämsby S; Hall H; Sällemark M; Angeby-Möller K; Ogren SO
J Med Chem; 1986 Jan; 29(1):61-9. PubMed ID: 3941414
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
25. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
[TBL] [Abstract][Full Text] [Related]
27. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
Köhler C; Hall H; Ogren SO; Gawell L
Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes.
Li XM; Hedlund PB; Agnati LF; Fuxe K
Brain Res; 1994 Jul; 650(2):289-98. PubMed ID: 7953694
[TBL] [Abstract][Full Text] [Related]
29. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
Löschmann PA; Smith LA; Lange KW; Jaehnig P; Jenner P; Marsden CD
Psychopharmacology (Berl); 1991; 105(3):303-9. PubMed ID: 1686813
[TBL] [Abstract][Full Text] [Related]
30. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
31. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
[TBL] [Abstract][Full Text] [Related]
32. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
33. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
Magnusson O; Fowler CJ; Mohringe B; Wijkström A; Ogren SO
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):379-84. PubMed ID: 2900472
[TBL] [Abstract][Full Text] [Related]
35. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Millan MJ; Bervoets K; Mavridis M
Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876
[TBL] [Abstract][Full Text] [Related]
36. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
[TBL] [Abstract][Full Text] [Related]
37. Dopamine receptors in canine caudate nucleus.
Maeno H
Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
[TBL] [Abstract][Full Text] [Related]
38. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
39. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
Hall H; Wedel I
Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
[TBL] [Abstract][Full Text] [Related]
40. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
Ogren SO; Rosén L; Fuxe K
Neuroscience; 1994 Jul; 61(2):269-83. PubMed ID: 7969908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
